Asthma Clinical Trials in Houston

Showing 161-180 of 359 trials

Tolerability and Efficacy of RJX in Patients With COVID-19

NCT04708340

This study is designed as a 2-part, 2-cohort, double-blind, randomized, placebo controlled, multicenter Phase 1/2 study to evaluate the safety, tolerability and efficacy of RJX in patients with COVID-19.

COVID-19Acute Respiratory Distress SyndromeSARS-CoV-2+1 more

Reven Pharmaceuticals, Inc.237 participantsStarted Mar 2021

Houston, Texas, United States • Houston, Texas, United States • New Braunfels, Texas, United States

UNKNOWNPhase 2/3< 1 mile

NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection

NCT04452565

This Phase 2/3 trial evaluates four treatment strategies for non-critically ill hospitalized participants (not requiring ICU admission and/or mechanical ventilation) with SARS CoV-2 infection, in which participants will receive NA-831 or Atazanavir with or without Dexamethasone.

Coronavirus InfectionSevere Acute Respiratory InfectionSevere Acute Respiratory Syndrome Coronavirus 2

Biomed Industries, Inc.525 participantsStarted Jun 2022

Los Angeles, California, United States • Orange, California, United States • Palo Alto, California, United States +28 more locations

Tolerability and Efficacy of RJX in Patients With COVID-19

NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection

Asthma Trials in Other Cities

Evaluation of Two Doses of QVAR by Breath Operated and Metered Dose Inhalers in Asthmatic Children

A Study to Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Asthma

Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma

Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma

A Study of the Safety and Effectiveness of Benralizumab to Treat Patients With Severe Uncontrolled Asthma.

Comparison of Two Bronchodilator Inhalers in Pediatric Asthmatics

Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE)

A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 4-11 Years Old With Persistent Asthma

A Study to Describe the Safety and Immunogenicity of a RSV Vaccine in Healthy Adults

Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients

Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma

Study of Reslizumab in Participants With Uncontrolled Asthma and Elevated Blood Eosinophils

Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)

Evaluation of Dupilumab in Children With Uncontrolled Asthma

Study to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI Compared to High Strength FLOVENT® DISKUS® and ADVAIR® DISKUS® in Patients With Persistent Asthma 12 Years of Age and Older

A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma

Study of Efficacy and Safety of LOU064 in Inadequately Controlled Asthma Patients

A Study to Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants With Moderate to Severe Allergic Asthma

Other Conditions in Houston